Ghrelin reverses experimental diabetic neuropathy in mice

Biochemical and Biophysical Research Communications

Volumn 389, Issue 3, 2009, Pages 405-408

  Kyoraku, Itaru ^a   Shiomi, Kazutaka ^a   Kangawa, Kenji ^b   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Diabetic neuropathy; Ghrelin; Nerve conduction velocity; Thermal sensation oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; GHRELIN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE SENSATION; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEAT SENSITIVITY; HOT PLATE TEST; INSULIN BLOOD LEVEL; MALE; MOTOR NERVE CONDUCTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; SCIATIC NERVE; SENSORY NERVE CONDUCTION; ANIMAL; C57BL MOUSE; EATING; EXPERIMENTAL DIABETES MELLITUS;

MUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; EATING; GHRELIN; MALE; MICE; MICE, INBRED C57BL;

EID: 70449727681     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.171     Document Type: Article

References (29)

1. P.J. Dyck, K.M. Kratz, J.L. Karnes, W.J. Litchy, R. Klein, J.M. Pach, D.M. Wilson, P.C. O'Brien, L.J. Melton 3rd., F.J. Service, The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study, Neurology 43 (1993) 817-824.
2. A.I. Vinik, T.S. Park, K.B. Stansberry, G.L. Pittenger, Diabetic neuropathies, Diabetologia 43 (2000) 957-973.
3. F. Roy, The nervous system and diabetes, in: C.R. Kahn, G.C. Weir, G.L. King, A.M. Jacobsen, A.C. Moses, R.J. Smith (Eds.), Joslin's Diabetes Mellitus, 14th ed., Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 951-968.
4. P.A. Low, Recent advances in the pathogenesis of diabetic neuropathy, Muscle Nerve 10 (1987) 121-128.
5. N.E. Cameron, M.A. Cotter, Metabolic and vascular factors in the pathogenesis of diabetic neuropathy, Diabetes 46 (Suppl. 2) (1997) S31-S37.
6. P. Rösen, P.P. Nawroth, G. King, W. Möller, H.J. Tritschler, L. Packer, The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society, Diabetes Metab. Res. Rev. 17 (2001) 189-212.
7. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature 402 (1999) 656-660.
8. Y. Date, K. Toshinai, S. Koda, M. Miyazato, T. Shimbara, T. Tsuruta, A. Niijima, K. Kangawa, M. Nakazato, Peripheral interaction of ghrelin with cholecystokinin on feeding regulation, Endocrinology 146 (2005) 3518-3525.
9. M. Tschöp, D.L. Smiley, M.L. Heiman, Ghrelin induces adiposity in rodents, Nature 407 (2000) 908-913.
10. M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, S. Matsukura, A role for ghrelin in the central regulation of feeding, Nature 409 (2001) 194-198.
11. M. Kojima, K. Kangawa, Drug Insight: the functions of ghrelin and its potential as a multitherapeutic hormone, Nat. Clin. Pract. Endocrinol. Metab. 2 (2006) 80-88.
12. P. Schratzberger, D.H. Walter, K. Rittig, F.H. Bahlmann, R. Pola, C. Curry, M. Silver, J.G. Krainin, D.H. Weinberg, A.H. Ropper, J.M. Isner, Reversal of experimental diabetic neuropathy by VEGF gene transfer, J. Clin. Invest. 107 (2001) 1083-1092.
13. Y.S. Chen, S.S. Chung, S.K. Chung, Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice, Diabetes 54 (2005) 3112-3118.
14. B. Kakinoki, S. Sekimoto, S. Yuki, T. Ohgami, M. Sejima, K. Yamagami, K. Saito, Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals, Diabetes 55 (2006) 616-621.
15. N.M. Neary, C.J. Small, A.M. Wren, J.L. Lee, M.R. Druce, C. Palmieri, G.S. Frost, M.A. Ghatei, R.C. Coombes, S.R. Bloom, Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial, J. Clin. Endocrinol. Metab. 89 (2004) 2832-2836.
16. N. Nagaya, T. Itoh, S. Murakami, H. Oya, M. Uematsu, K. Miyatake, K. Kangawa, Treatment of cachexia with ghrelin in patients with COPD, Chest 128 (2005) 1187-1193.
17. D. Miljic, S. Pekic, M. Djurovic, M. Doknic, N. Milic, F.F. Casanueva, M. Ghatei, V. Popovic, Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa, J. Clin. Endocrinol. Metab. 91 (2006) 1491-1495.
18. T. Kodama, J. Ashitani, N. Matsumoto, K. Kangawa, M. Nakazato, Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection, Pulm. Pharmacol. Ther. 21 (2008) 774-779.
19. F. Strasser, T.A. Lutz, M.T. Maeder, B. Thuerlimann, D. Bueche, M. Tschöp, K. Kaufmann, B. Holst, M. Brändle, R. von Moos, R. Demmer, T. Cerny, Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, doublecrossover study, Br. J. Cancer 98 (2008) 300-308.
20. P.A. Low, K.K. Nickander, H.J. Tritschler, The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy, Diabetes 46 (Suppl. 2) (1997) S38-S42.
21. H. Zhao, G. Liu, Q. Wang, L. Ding, H. Cai, H. Jiang, Z. Xin, Effect of ghrelin on human endothelial cells apoptosis induced by high glucose, Biochem. Biophys. Res. Commun. 326 (2007) 677-681.
22. E.E. Eter, A.A. Tuwaijiri, H. Hagar, M. Arafa, In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat, J. Gastroenterol. Hepatol. 22 (2007) 1791-799.
23. G. Baldanzi, N. Filigheddu, S. Cutrupi, F. Catapano, S. Bonissoni, A. Fubini, D. Malan, G. Baj, R. Granata, F. Broglio, M. Papotti, N. Surico, F. Bussolino, J. Isgaard, R. Deghenghi, F. Sinigaglia, M. Prat, G. Muccioli, E. Ghigo, A. Graziani, Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT, J. Cell Biol. 159 (2004) 1029-1037.
24. N.M. Thompson, D.A. Gill, R. Davies, N. Loveridge, P.A. Houston, I.C. Robinson, T. Wells, Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor, Endocrinology 145 (2004) 234-242.
25. G. Muccioli, N. Pons, C. Ghè, F. Catapano, R. Granata, E. Ghigo, Ghrelin and desacyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor, Eur. J. Pharmacol. 498 (2004) 27-35.
26. A.M. Nanzer, S. Khalaf, A.M. Mozid, R.C. Fowkes, M.V. Patel, J.M. Burrin, A.B. Grossman, M. Korbonits, Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway, Eur. J. Endocrinol. 151 (2004) 233-240.
27. P.J. Delhanty, B.C. van der Eerden, M. van der Velde, C. Gauna, H.A. Pols, H. Jahr, H. Chiba, A.J. van der Lely, J.P. van Leeuwen, Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHSR1a, J. Endocrinol. 188 (2006) 37-47.
28. K. Toshinai, H. Yamaguchi, Y. Sun, R.G. Smith, A. Yamanaka, T. Sakurai, Y. Date, M.S. Mondal, T. Shimbara, T. Kawagoe, N. Murakami, M. Miyazato, K. Kangawa, M. Nakazato, Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor, Endocrinology 147 (2006) 2306-2314.
29. N. Filigheddu, V.F. Gnocchi, M. Coscia, M. Cappelli, P.E. Porporato, R. Taulli, S. Traini, G. Baldanzi, F. Chianale, S. Cutrupi, E. Arnoletti, C. Ghè, A. Fubini, N. Surico, F. Sinigaglia, C. Ponzetto, G. Muccioli, T. Crepaldi, A. Graziani, Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells, Mol. Biol. Cell 18 (2007) 986-994.